Literature DB >> 22612014

Distinguishing small primary lung cancer from pulmonary tuberculoma using 64-slices multidetector CT.

Kanyarat Totanarungroj1, Sutasinee Chaopotong, Trongtum Tongdee.   

Abstract

OBJECTIVE: To evaluate which CT findings help in distinguishing small primary lung cancer from tuberculoma. MATERIAL AND
METHOD: Forty-two chest CT studies with pathological diagnosis of primary lung cancer (n = 27) and tuberculoma (n = 15) were retrospectively reviewed by two radiologists who were blind to the pathological results. The CT findings of number; size, shape, border and location of the nodules, the presence or absence of satellite nodule, contrast enhancement, internal air bronchogram, internal calcification, internal cavitation, bronchovascular invasion, and bony destruction were evaluated.
RESULTS: About 96% of primary lung cancer had a solitary lesion compared to only 60% among tuberculoma (p < 0.05). The nodule size > 2-3 cm is more likely to be primary lung cancer compared with tuberculoma (p = 0.058). Both primary lung cancer and tuberculoma can occur in all lobes of both lungs but more frequently in the upper lobe, which has no statistically significant difference between these two groups. Tuberculoma seems to be round or polygonal shape and primary lung cancer is more likely to be lobulated shape. The smooth border nodule is found only in tuberculoma (27%) whereas 93% of primary lung cancer had spiculated border compared to 73% among tuberculoma (p < 0.05). Tuberculoma seems to have more satellite nodule than primary lung cancer (47% vs. 22%, p = 0.163). The enhancement of nodule and air bronchogram are significantly found in primary lung cancer compared with tuberculoma (p < 0.05). Tuberculoma seems to have dense central calcification and primary lung cancer seems to have punctate calcification (p < 0.05). Most of the primary lung cancer and tuberculoma do not have internal cavity. The presence of bronchovascular invasion was significantly found in primary lung cancer compared with tuberculoma (p < 0.05). No evidence of bony destruction was observed in both pulmonary tuberculoma and primary lung cancer groups.
CONCLUSION: The solitary lesion size < 3 cm in diameter with spiculated border contrast enhancement, presence of air bronchogram, punctate calcification and bronchovascular invasion are useful CT findings for diagnosis of primary lung cancer However, the lesions with inconclusive findings, tissue diagnosis may be necessary.

Entities:  

Mesh:

Year:  2012        PMID: 22612014

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  [18F-FDG PET/CT manifestations of massive type active pulmonary tuberculosis and its differentiation from lung cancer].

Authors:  Jiamei Gu; Yunyan Ren; Xiaohui Chen; Yanping Jiang; Wenlan Zhou; Lijuan Wang; Yanjiang Han; Qiaoyu Wang; Hubing Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

2.  Clinical and Computed Tomography Characteristics of Solitary Pulmonary Nodules Caused by Fungi: A Comparative Study.

Authors:  Jin Jiang; Zhuo-Ma Lv; Fa-Jin Lv; Bin-Jie Fu; Zhang-Rui Liang; Zhi-Gang Chu
Journal:  Infect Drug Resist       Date:  2022-10-18       Impact factor: 4.177

3.  Successful desensitization therapy involving fluoroquinolone for the treatment of a solitary tuberculoma: A case report and literature review.

Authors:  Hidehiro Watanabe; Tomonori Uruma; Ikuo Seita; Yushi Chikasawa; Ryota Kikuchi; Masayuki Itoh; Kazutetsu Aoshiba; Hiroyuki Nakamura; Tsuyoshi Oishi
Journal:  Mol Clin Oncol       Date:  2016-04-28

4.  The value of the air bronchogram sign on CT image in the identification of different solitary pulmonary consolidation lesions.

Authors:  Huifang Qu; Wenchao Zhang; Jisheng Yang; Shouqin Jia; Guangbin Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  Clinical and Computed Tomography (CT) Characteristics of Pulmonary Nodules Caused by Cryptococcal Infection.

Authors:  Fang Chen; Yuan-Bing Liu; Bin-Jie Fu; Fa-Jin Lv; Zhi-Gang Chu
Journal:  Infect Drug Resist       Date:  2021-10-14       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.